• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

870 例鼻咽癌区域淋巴结转移分布及调强放疗个体化选择性预防照射的建议。

Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy.

机构信息

Department of Radiotherapy, Peking University Cancer Hospital Yunnan, The Third Affiliated Hospital of Kunming Medical University, Yunnan Cancer Hospital, Yunnan Cancer Center, Kunming Yunnan, P.R. China.

Department of Radiation Oncology, Hunan Cancer Hospital & the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha Hunan, P.R. China.

出版信息

Cancer Med. 2024 Feb;13(3):e6723. doi: 10.1002/cam4.6723. Epub 2023 Dec 29.

DOI:10.1002/cam4.6723
PMID:38156901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10905225/
Abstract

PURPOSE

To explore the feasibility of individualized elective prophylactic neck irradiation (iEPNI) for optimizing current approach by investigating metastatic lymph nodes (LNs) distribution in nasopharyngeal carcinoma (NPC).

MATERIALS AND METHODS

Records of 870 NPC patients without distant metastasis in Hunan Cancer Hospital from January 2019 to December 2019 were reviewed. LNs' locations were identified based on the 2013 guidelines. The intra-regional lymphatic drainage (IRLD) areas included Station 1st (level VIIa and II), Station 2nd (level III and Va), and Station 3rd (level IV, Vb, and Vc). Other levels were categorized as extra-regional areas.

RESULTS

Among the 870 patients, 94.5% cases exhibited LNs metastasis, including unilateral metastasis in 198 patients and bilateral metastasis in 624 patients. In the whole cohort, the most common involved IRLD areas were level IIb (87.1%), VIIa (80.0%), IIa (61.8%), Va (30.6%), IV (21.4%), Vb (8.9%), and Vc (1.1%). Besides, rates of LNs metastasis in Station 1st, 2nd, and 3rd were 94.3%, 61.1%, and 22.9%, respectively. Only four patients (4, 0.5%) revealed skipping metastasis among the three stations.

CONCLUSIONS

Lymph node metastasis follows an organized pattern from Station 1st to 3rd with scarce skipping metastasis. A potential iEPNI strategy of prophylactic neck irradiation to the ipsilateral latter node-negative station appears promising in NPC patients. Further prospective investigations are warranted to validate the approach.

摘要

目的

通过研究鼻咽癌(NPC)转移淋巴结(LNs)的分布,探讨个体化选择性预防性颈部照射(iEPNI)优化当前治疗策略的可行性。

材料与方法

回顾 2019 年 1 月至 12 月在湖南省肿瘤医院就诊的 870 例无远处转移的 NPC 患者的病历资料。基于 2013 年的指南确定 LNs 的位置。区域性淋巴结引流(IRLD)区域包括第 1 站(水平 VIIa 和 II)、第 2 站(水平 III 和 Va)和第 3 站(水平 IV、Vb 和 Vc)。其他水平被归类为区域外区域。

结果

在 870 例患者中,94.5%的患者存在 LNs 转移,其中 198 例为单侧转移,624 例为双侧转移。在整个队列中,最常见的累及 IRLD 区域为水平 IIb(87.1%)、VIIa(80.0%)、IIa(61.8%)、Va(30.6%)、IV(21.4%)、Vb(8.9%)和 Vc(1.1%)。此外,第 1 站、第 2 站和第 3 站的 LNs 转移率分别为 94.3%、61.1%和 22.9%。三个站中仅有 4 例(4,0.5%)存在跳跃性转移。

结论

淋巴结转移呈从第 1 站到第 3 站的有序模式,跳跃性转移很少见。对于 NPC 患者,采用同侧无后者淋巴结阴性站的个体化选择性预防性颈部照射(iEPNI)策略可能具有广阔的应用前景。需要进一步的前瞻性研究来验证该方法。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/0470b4dcfd6b/CAM4-13-e6723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/0470b4dcfd6b/CAM4-13-e6723-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fc15/10905225/5592ac0e3046/CAM4-13-e6723-g001.jpg

相似文献

1
Distribution of regional lymph nodes metastasis in 870 cases of nasopharyngeal carcinoma and the suggestions for individualized elective prophylactic neck irradiation with intensity-modulated radiotherapy.870 例鼻咽癌区域淋巴结转移分布及调强放疗个体化选择性预防照射的建议。
Cancer Med. 2024 Feb;13(3):e6723. doi: 10.1002/cam4.6723. Epub 2023 Dec 29.
2
Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.单侧鼻咽癌区域淋巴结转移分布及调强放疗选择性预防照射的建议。
Cancer Med. 2023 Nov;12(21):20511-20520. doi: 10.1002/cam4.6614. Epub 2023 Oct 25.
3
Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.鼻咽癌IB期淋巴结转移的危险因素及分布特征
Auris Nasus Larynx. 2019 Jun;46(3):457-464. doi: 10.1016/j.anl.2018.10.012. Epub 2018 Dec 6.
4
Distribution pattern and prognosis of metastatic lymph nodes in cervical posterior to level V in nasopharyngeal carcinoma patients.鼻咽癌患者颈 V 水平后区转移性淋巴结的分布模式与预后。
BMC Cancer. 2020 Jul 17;20(1):667. doi: 10.1186/s12885-020-07146-z.
5
Delineation of reduced CTV2 on the basis of the characteristics and distribution of cervical lymph node metastasis in nasopharyngeal carcinoma.基于鼻咽癌颈部淋巴结转移的特征及分布勾画缩小的临床靶区2(CTV2)。
BMC Cancer. 2025 Jan 25;25(1):145. doi: 10.1186/s12885-025-13498-1.
6
Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.颈部淋巴结阴性鼻咽癌患者全颈与上颈预防性照射的比较研究
Head Neck. 2014 May;36(5):687-93. doi: 10.1002/hed.23359. Epub 2013 Oct 17.
7
The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.基于2013年更新的颈部淋巴结分区共识指南,对低危鼻咽癌患者省略IB区淋巴结选择性照射的可行性分析
Radiat Oncol. 2017 Aug 18;12(1):137. doi: 10.1186/s13014-017-0869-x.
8
Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.仅伴有咽后淋巴结转移的鼻咽癌治疗转归及选择性颈淋巴结照射的可行性。
Oral Oncol. 2012 Oct;48(10):1045-1050. doi: 10.1016/j.oraloncology.2012.04.011. Epub 2012 May 24.
9
Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.鼻咽癌患者采用调强放射治疗选择性照射颈部Ib区的可行性研究:一项回顾性分析
BMC Cancer. 2015 Oct 15;15:709. doi: 10.1186/s12885-015-1669-z.
10
Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).960例鼻咽癌颈部淋巴结分区的相关性分析
Radiother Oncol. 2021 Aug;161:23-28. doi: 10.1016/j.radonc.2021.05.020. Epub 2021 May 25.

引用本文的文献

1
Predictive Effect of Prognostic Nutritional Index on Lymph Node Regression Rate in Patients with Locally Advanced Nasopharyngeal Carcinoma Undergoing Concurrent Chemoradiotherapy.预后营养指数对局部晚期鼻咽癌同步放化疗患者淋巴结消退率的预测作用
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251356541. doi: 10.1177/15330338251356541. Epub 2025 Jul 2.
2
A prognostic nomogram based on lymph node skipping metastases in esophageal squamous cell carcinoma.基于食管鳞状细胞癌淋巴结跳跃转移的预后列线图。
J Thorac Dis. 2025 Apr 30;17(4):1942-1957. doi: 10.21037/jtd-24-1798. Epub 2025 Apr 27.
3
PTEN as a prognostic factor for radiotherapy plus immunotherapy response in nasopharyngeal carcinoma.

本文引用的文献

1
Upper-neck irradiation versus standard whole-neck irradiation in nasopharyngeal carcinoma: A systematic review and meta-analysis.上颈部放疗与鼻咽癌标准全颈放疗的比较:系统评价和荟萃分析。
Tumori. 2023 Dec;109(6):529-536. doi: 10.1177/03008916231154765. Epub 2023 Feb 16.
2
Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?未累及颈部的鼻咽癌患者采用质子治疗保留下颈部:安全吗?
J Clin Med. 2022 Jun 9;11(12):3297. doi: 10.3390/jcm11123297.
3
Characteristics of locoregional extension of unilateral nasopharyngeal carcinoma and suggestions for clinical target volume delineation.
PTEN作为鼻咽癌放疗联合免疫治疗反应的预后因素。
J Nanobiotechnology. 2025 Apr 21;23(1):303. doi: 10.1186/s12951-025-03315-z.
4
A combination of Dihydroartemisinin and Venetoclax enhances antitumor effect in AML via C-MYC/BCL-XL/MCL-1 triple targeting.双氢青蒿素与维奈托克联合使用通过C-MYC/BCL-XL/MCL-1三联靶向增强急性髓系白血病的抗肿瘤作用。
Discov Oncol. 2025 Apr 9;16(1):496. doi: 10.1007/s12672-025-02242-7.
5
High Expression of GPR183 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia.GPR183高表达预示细胞遗传学正常的急性髓系白血病患者预后不良。
Biochem Genet. 2025 Jan 16. doi: 10.1007/s10528-025-11026-1.
6
Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy.长非编码 RNA 在癌症中的作用:多方面的角色和免疫治疗的潜在靶点。
Mol Cell Biochem. 2024 Dec;479(12):3229-3254. doi: 10.1007/s11010-024-04933-1. Epub 2024 Feb 28.
单侧鼻咽癌局部区域扩展的特征及临床靶区勾画建议。
Radiat Oncol. 2022 Mar 12;17(1):52. doi: 10.1186/s13014-022-02017-2.
4
Elective upper-neck versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: an open-label, non-inferiority, multicentre, randomised phase 3 trial.选择性上颈部与不涉及颈部的全颈部照射治疗鼻咽癌患者的疗效比较:一项开放标签、非劣效性、多中心、随机 3 期临床试验。
Lancet Oncol. 2022 Apr;23(4):479-490. doi: 10.1016/S1470-2045(22)00058-4. Epub 2022 Feb 28.
5
The Chinese Society of Clinical Oncology (CSCO) clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma.中国临床肿瘤学会(CSCO)鼻咽癌诊断与治疗临床指南。
Cancer Commun (Lond). 2021 Nov;41(11):1195-1227. doi: 10.1002/cac2.12218. Epub 2021 Oct 26.
6
Correlation analysis of neck node levels in 960 cases of Nasopharyngeal carcinoma (NPC).960例鼻咽癌颈部淋巴结分区的相关性分析
Radiother Oncol. 2021 Aug;161:23-28. doi: 10.1016/j.radonc.2021.05.020. Epub 2021 May 25.
7
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.头颈部癌症临床实践指南(2020 年第 2 版),NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2020 Jul;18(7):873-898. doi: 10.6004/jnccn.2020.0031.
8
Oncologic outcomes of IMRT versus CRT for nasopharyngeal carcinoma: A meta-analysis.调强适形放疗与同步放化疗治疗鼻咽癌的肿瘤学结局:一项荟萃分析。
Medicine (Baltimore). 2019 Jun;98(24):e15951. doi: 10.1097/MD.0000000000015951.
9
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
10
Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study).香港调强放疗时代鼻咽癌的治疗结果:3328 例患者报告(HKNPCSG 1301 研究)。
Oral Oncol. 2018 Feb;77:16-21. doi: 10.1016/j.oraloncology.2017.12.004. Epub 2017 Dec 12.